QuidelOrtho Gets CLIA Waiver for COVID Rapid Test
QuidelOrtho, a provider of innovative in vitro diagnostic technologies designed for point-of-care...
Read MorePosted by Andy Lundin | Sep 22, 2023 | Covid 19 |
QuidelOrtho, a provider of innovative in vitro diagnostic technologies designed for point-of-care...
Read MorePosted by Andy Lundin | Sep 21, 2023 | Point-of-Care |
An interdisciplinary team received a grant to launch a center for engineering, testing, and commercializing point-of-care diagnostic devices.
Read MorePosted by Chris Wolski | Sep 19, 2023 | Infectious Diseases |
The infectious disease test developed by the Rutgers researchers employs nanoballs and combines that technology with advanced electronics.
Read MorePosted by Andy Lundin | Sep 18, 2023 | Diagnostic Technologies |
The Icahn School of Medicine at Mount Sinai agreed to an exclusive license option with GNOMX Corp. for the disease diagnostic tech.
Read MorePosted by Andy Lundin | Sep 13, 2023 | Clinical Chemistry Analyzers |
Carolina Liquid Chemistries Corp. now offers urine drug screens on the Diazyme DZ-Lite c270 benchtop clinical chemistry analyzer.
Read More